Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 1, 1994
The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer
V Bhargava, A Thor, G Deng, et al.
The New England Journal of Medicine
|
March 17, 1994
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma
V L Cryns, A Thor, H J Xu, et al.
International Journal of Cancer
|
January 15, 1987
Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3
J M Esteban, D Colcher, P Sugarbaker, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1989
Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP
J A Radosevich, S G Combs, Y Ma, et al.
Cancer Research
|
August 15, 1988
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen
R Muraro, M Kuroki, D Wunderlich, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 1992
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
O P Kallioniemi, A Kallioniemi, W Kurisu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 1, 1986
ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues
A Thor, N Ohuchi, P H Hand, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1989
Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms
J A Radosevich, V E Gould, Y Ma, et al.
Cancer Treatment and Research
|
January 1, 1990
Tumor targeting with monoclonal antibody B72.3: experimental and clinical results
J Schlom, D Colcher, K Siler, et al.
Oncogene
|
October 31, 1997
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer
C C Benz, R C O'Hagan, B Richter, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 1, 1994
The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer
V Bhargava, A Thor, G Deng, et al.
The New England Journal of Medicine
|
March 17, 1994
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma
V L Cryns, A Thor, H J Xu, et al.
International Journal of Cancer
|
January 15, 1987
Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3
J M Esteban, D Colcher, P Sugarbaker, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1989
Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP
J A Radosevich, S G Combs, Y Ma, et al.
Cancer Research
|
August 15, 1988
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen
R Muraro, M Kuroki, D Wunderlich, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 1992
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
O P Kallioniemi, A Kallioniemi, W Kurisu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 1, 1986
ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues
A Thor, N Ohuchi, P H Hand, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|
January 1, 1989
Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms
J A Radosevich, V E Gould, Y Ma, et al.
Cancer Treatment and Research
|
January 1, 1990
Tumor targeting with monoclonal antibody B72.3: experimental and clinical results
J Schlom, D Colcher, K Siler, et al.
Oncogene
|
October 31, 1997
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer
C C Benz, R C O'Hagan, B Richter, et al.
Page
of 9